Agilent Technologies Inc (A)vsBiodesix Inc (BDSX)
A
Agilent Technologies Inc
$161.94
+3.50%
HEALTHCARE · Cap: $44.12B
BDSX
Biodesix Inc
$28.43
-2.64%
HEALTHCARE · Cap: $284.51M
Smart Verdict
WallStSmart Research — data-driven comparison
Agilent Technologies Inc generates 7062% more annual revenue ($7.37B vs $102.94M). A leads profitability with a 19.5% profit margin vs -27.0%. A earns a higher WallStSmart Score of 63/100 (C+).
A
Buy63
out of 100
Grade: C+
BDSX
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-65.8%
Fair Value
$77.73
Current Price
$161.94
$84.21 premium
Margin of Safety
-8.5%
Fair Value
$9.54
Current Price
$28.43
$18.89 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 25.6%
Revenue surging 34.2% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
Grey zone — moderate risk
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
Trading at 32.7x book value
ROE of -349.9% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Operating Margin. Profitability is solid with margins at 19.5% and operating margin at 25.6%. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bull Case : BDSX
The strongest argument for BDSX centers on Revenue Growth. Revenue growth of 34.2% demonstrates continued momentum.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : BDSX
The primary concerns for BDSX are EPS Growth, Market Cap, Price/Book. Debt-to-equity of 7.85 is elevated, increasing financial risk.
Key Dynamics to Monitor
A profiles as a mature stock while BDSX is a hypergrowth play — different risk/reward profiles.
A carries more volatility with a beta of 1.24 — expect wider price swings.
BDSX is growing revenue faster at 34.2% — sustainability is the question.
A generates stronger free cash flow (439M), providing more financial flexibility.
Bottom Line
A scores higher overall (63/100 vs 29/100), backed by strong 19.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Biodesix Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?